机构地区:[1]Academy of Integrative Medicine,Fujian University of Traditional Chinese Medicine
出 处:《Chinese Journal of Integrative Medicine》2011年第9期691-697,共7页中国结合医学杂志(英文版)
基 金:Supported by CHEN Ke-ji Integrative Medicine Development Fund(No.CKJ2010020);International Science Joint Project of the Ministry of Science and Technology of the People's Republic of China(No.2008DFA32200);Project of Department of Education of Fujian Province(No.JA09136)
摘 要:Objective:To study the inhibitory effect of Fuzheng Yiliu Granule(扶正抑瘤颗粒,FYG) on hepatocellular cancer(HCC) and investigate the mechanism mediating its bioactivity.Methods:H22 tumor-bearing ICR mice were treated with FYG[3.6 g/(kg·d)]for 5 days.Tumor volume and tumor weight,percentages of CD3~+,CD4~+,CD8~+,and natural killer(NK) cells in peripheral blood,tumor apoptosis and serum levels of interleukin-2(IL-2),and tumor necrosis factor-α(TNF-α) were evaluated.FYG-containing serum was prepared from SD rats treated for 7 days[high dose 3.6 g/(kg·d);middle dose 1.8 g/(kg·d);low dose 0.9 g/(kg·d)].Cell cycle,cell viability,and apoptosis were evaluated after HepG2 cell line was cultured in FYG-containing serum for 48 h.The levels of IL-2 and TNF-αin FYG-containing serum were also determined.Results:FYG produced a potent antitumor effect(P0.01) and induced marked apoptosis of the tumor tissue(P0.05).Mice treated with FYG had higher percentages of CD3~+ and CD4~+(P0.05),and more NK cells(P0.01) in the peripheral blood than those in the animals treated with normal saline.Mice receiving FYG had the highest serum levels of IL-2 and TNF-α(P0.01).High-dose FYG-containing serum significantly decreased HepG2 cell viability,inhibited cell proliferation(P0.05),and induced apoptosis(P0.01).In addition,the levels of IL-2 and TNF-αof highdose -containing serum were higher than the blank serum(P0.01).Conclusion:FYG could inhibit HCC growth by regulating immune function and inducing apoptosis of tumor cells in vivo and in vitro.Objective:To study the inhibitory effect of Fuzheng Yiliu Granule(扶正抑瘤颗粒,FYG) on hepatocellular cancer(HCC) and investigate the mechanism mediating its bioactivity.Methods:H22 tumor-bearing ICR mice were treated with FYG[3.6 g/(kg·d)]for 5 days.Tumor volume and tumor weight,percentages of CD3~+,CD4~+,CD8~+,and natural killer(NK) cells in peripheral blood,tumor apoptosis and serum levels of interleukin-2(IL-2),and tumor necrosis factor-α(TNF-α) were evaluated.FYG-containing serum was prepared from SD rats treated for 7 days[high dose 3.6 g/(kg·d);middle dose 1.8 g/(kg·d);low dose 0.9 g/(kg·d)].Cell cycle,cell viability,and apoptosis were evaluated after HepG2 cell line was cultured in FYG-containing serum for 48 h.The levels of IL-2 and TNF-αin FYG-containing serum were also determined.Results:FYG produced a potent antitumor effect(P0.01) and induced marked apoptosis of the tumor tissue(P0.05).Mice treated with FYG had higher percentages of CD3~+ and CD4~+(P0.05),and more NK cells(P0.01) in the peripheral blood than those in the animals treated with normal saline.Mice receiving FYG had the highest serum levels of IL-2 and TNF-α(P0.01).High-dose FYG-containing serum significantly decreased HepG2 cell viability,inhibited cell proliferation(P0.05),and induced apoptosis(P0.01).In addition,the levels of IL-2 and TNF-αof highdose -containing serum were higher than the blank serum(P0.01).Conclusion:FYG could inhibit HCC growth by regulating immune function and inducing apoptosis of tumor cells in vivo and in vitro.
关 键 词:Fuzheng Yiliu Granule hepatocellular cancer immune function APOPTOSIS
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...